Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)-a single region experience on consecutive patients
| Image |  |
|---|---|
| Description | scientific article published on 21 May 2014 |
| Author/s |
author: Lotta Hansson Marzia Palma |
| Publication date | May 21, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |